4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Spinal Injuries: new trials by email Literature Review of Spinal Injuries trials Research Report on Spinal Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery Dantrolene, Placebo Oral Tablet - Lumbar Spine Injury | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 116 | 2019-07-29 | 2026-06-18 |
| Dose Escalation Study of AST-OPC1 in Spinal Cord Injury AST-OPC1 - Cervical Spinal Cord Injury, Spine Injury | Phase 1 / Phase 2 | Completed | Lineage Cell Therapeutics, Inc. | 25 | 2015-03-01 | 2021-07-14 |
| Effectiveness of Physiotherapy for Osteoporotic Spinal Fracture Physiotherapy - Osteoporosis, Vertebral Fracture | Phase 2 | Completed | University of Melbourne | 20 | 2006-02-01 | 2025-07-10 |
| Treatment of Childhood Osteoporosis With Alendronate (Fosamax) Alendronate - Osteoporosis | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 50 | 1998-03-01 | 2016-09-22 |
Osteoporosis (2) · Spinal Fractures (2) · Pain (1) · Paralysis (1) · Quadriplegia (1) · Spinal Cord Injuries (1)
Back Injuries (4) · Wounds and Injuries (4) · Bone Diseases (2) · Bone Diseases, Metabolic (2) · Fractures, Bone (2) · Metabolic Diseases (2) · Musculoskeletal Diseases (2) · Neurologic Manifestations (2) · Nutritional and Metabolic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Central Nervous System Diseases (1) · Nervous System Diseases (1) · Spinal Cord Diseases (1)
Alendronate (1) · Dantrolene (1) · Physical Therapy Modalities (1)
Beth Israel Deaconess Medical Center (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Lineage Cell Therapeutics, Inc. (1) · University of Melbourne (1)
United States (3) · Australia (1)
Kim L Bennell, PhD (1) · Richard J Pollard, MD (1)